TABLE OF CONTENTS
1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.3 OVERVIEW OF GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET 34
1.4 LIMITATIONS 36
1.5 MARKETS COVERED 36
2 MARKET SEGMENTATION 38
2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 CURRENCY AND PRICING 40
2.5 DBMR TRIPOD DATA VALIDATION MODEL 41
2.6 MULTIVARIATE MODELLING 44
2.7 PRODUCT LIFELINE CURVE 44
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
2.9 DBMR MARKET POSITION GRID 46
2.10 MARKET APPLICATION COVERAGE GRID 47
2.11 SECONDARY SOURCES 48
2.12 ASSUMPTIONS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 52
4.1 PORTER'S FIVE FORCES 54
4.1.1 THE THREAT OF NEW ENTRANTS 54
4.1.2 THE THREAT OF SUBSTITUTES 55
4.1.3 CUSTOMER BARGAINING POWER 56
4.1.4 SUPPLIER BARGAINING POWER 56
4.1.5 INTERNAL COMPETITION (RIVALRY) 57
4.2 CONSUMER LEVEL TRENDS OF GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET 58
4.2.1 OVERVIEW 58
4.2.2 HEALTH BENEFITS FROM AMINO ACIDS-BASED DIETARY SUPPLEMENTS 58
4.2.3 CERTIFIED AND RELIABLE PRODUCTS 59
4.2.4 ON-THE-GO FOOD PRODUCTS 59
4.3 FACTOR INFLUENCING PURCHASE DECISION 60
4.3.1 HIGH NUTRITIONAL VALUE 60
4.3.2 PRICING OF THE AMINO ACIDS 60
4.3.3 HIGH QUALITY 61
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 62
4.5 IMPACT OF ECONOMIC SLOWDOWN ON THE MARKET 63
4.5.1 IMPACT OF COVID-19 63
4.5.2 IMPACT OF WAR 63
4.5.3 IMPACT ON SUPPLY CHAIN 64
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 65
4.6.1 RISING ADOPTION OF ADVANCED TECHNOLOGIES AND NEW BENEFICIAL FORMULATIONS IN NEW PRODUCT DEVELOPMENT OF AMINO ACIDS IN THE DIETARY SUPPLEMENT INDUSTRY 65
4.6.2 CERTIFICATIONS & LABELLING CLAIMS AMONG MANUFACTURERS 66
4.6.3 BUSINESS EXPANSIONS THROUGH DIFFERENT STRATEGIC DECISIONS 66
4.6.4 FUTURE PERSPECTIVE 67
5 SUPPLY CHAIN ANALYSIS 68
5.1 RAW MATERIAL PROCUREMENT 69
5.2 PROCESSING AND MANUFACTURING 69
5.3 MARKETING AND DISTRIBUTION 69
5.4 END USERS 70
6 VALUE CHAIN ANALYSIS 71
7 REGULATORY FRAMEWORK AND GUIDELINES 73
8 MARKET OVERVIEW 76
8.1 DRIVERS 78
8.1.1 INCREASING DEMAND FOR AMINO ACID-BASED DIETARY SUPPLEMENTS DUE TO THE HEALTH AND NUTRITIONAL BENEFITS 78
8.1.2 RISING BIOTECHNOLOGICAL ADVANCEMENT IN AMINO ACID PRODUCTION FOR DIETARY SUPPLEMENTS 78
8.1.3 INCREASING LAUNCHES OF AMINO ACID-BASED DIETARY SUPPLEMENTS IN THE MARKET 79
8.1.4 GROWING A SUSTAINABLE AND WELL-ESTABLISHED SUPPLY CHAIN IN THE MARKET 80
8.2 RESTRAINTS 81
8.2.1 AVAILABILITY OF SUBSTITUTES FOR AMINO ACID-BASED DIETARY SUPPLEMENTS 81
8.2.2 STRINGENT GOVERNMENT REGULATIONS 81
8.3 OPPORTUNITIES 82
8.3.1 RISING AWARENESS AMONG CONSUMERS TOWARDS CONSUMPTION OF AMINO ACID-BASED DIETARY SUPPLEMENTS 82
8.3.2 INCREASING BUSINESS ACTIVITIES AND INVESTMENTS DONE BY THE DIETARY SUPPLEMENTS PRODUCERS IN THE MARKET 83
8.4 CHALLENGES 83
8.4.1 COMPLEX MANUFACTURING PROCESS 83
8.4.2 RISING AWARENESS REGARDING THE SIDE EFFECTS CAUSED BY OVERCONSUMPTION OF AMINO ACID 84
8.4.3 INCREASING R&D ON PERSONALIZED NUTRITION 85
9 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY TYPE 86
9.1 OVERVIEW 87
9.2 GLUTAMIC ACID 88
9.3 METHIONINE 90
9.4 LYSINE 91
9.5 PHENYLALANINE 92
9.6 TRYPTOPHAN 93
9.7 OTHERS 94
10 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY FORM 96
10.1 OVERVIEW 97
10.2 POWDERS 98
10.3 LIQUIDS 100
10.4 SOFT GELS 101
10.5 TABLETS 102
10.6 CAPSULES 103
10.7 GUMMIES 104
10.8 OTHERS 105
11 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY APPLICATION 107
11.1 OVERVIEW 108
11.2 ENERGY & WEIGHT MANAGEMENT 110
11.3 IMMUNITY 111
11.4 GENERAL HEALTH 112
11.5 BONE & JOINT HEALTH 114
11.6 DIABETES 115
11.7 GASTROINTESTINAL HEALTH 116
11.8 CARDIAC HEALTH 117
11.9 ANTI-CANCER 118
11.10 OTHERS 119
12 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY END USER 121
12.1 OVERVIEW 122
12.2 ADULTS 123
12.3 GERIATRIC 125
12.4 PREGNANT WOMEN 126
12.5 CHILDREN 127
12.6 INFANTS 128
13 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 130
13.1 OVERVIEW 131
13.2 OTC 132
13.3 PRESCRIBED 133
14 GLOBAL AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY REGION 135
14.1 OVERVIEW 136
14.2 NORTH AMERICA 142
14.2.1 U.S. 151
14.2.2 CANADA 155
14.2.3 MEXICO 159
14.3 EUROPE 163
14.3.1 GERMANY 173
14.3.2 SPAIN 177
14.3.3 FRANCE 181
14.3.4 ITALY 185
14.3.5 U.K. 189
14.3.6 NETHERLANDS 193
14.3.7 BELGIUM 197
14.3.8 SWITZERLAND 201
14.3.9 RUSSIA 205
14.3.10 TURKEY 209
14.3.11 REST OF EUROPE 213
14.4 ASIA-PACIFIC 214
14.4.1 CHINA 224
14.4.2 INDIA 228
14.4.3 JAPAN 232
14.4.4 AUSTRALIA 236
14.4.5 SOUTH KOREA 240
14.4.6 INDONESIA 244
14.4.7 PHILIPPINES 248
14.4.8 THAILAND 252
14.4.9 MALAYSIA 256
14.4.10 SINGAPORE 260
14.4.11 REST OF ASIA-PACIFIC 264
14.5 SOUTH AMERICA 265
14.5.1 BRAZIL 274
14.5.2 ARGENTINA 278
14.5.3 REST OF SOUTH AMERICA 282
14.6 MIDDLE EAST AND AFRICA 283
14.6.1 SAUDI ARABIA 292
14.6.2 U.A.E 296
14.6.3 SOUTH AFRICA 300
14.6.4 KUWAIT 304
14.6.5 REST OF MIDDLE EAST AND AFRICA 308
15 COMPANY LANDSCAPE 309
15.1 COMPANY SHARE ANALYSIS: GLOBAL 309
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 310
15.3 COMPANY SHARE ANALYSIS: EUROPE 311
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 312
16 SWOT ANALYSIS 313
17 COMPANY PROFILES 314
17.1 EVONIK INDUSTRIES AG 314
17.1.1 COMPANY SNAPSHOT 314
17.1.2 REVENUE ANALYSIS 314
17.1.3 COMPANY SHARE ANALYSIS 315
17.1.4 PRODUCT PORTFOLIO 315
17.1.5 RECENT DEVELOPMENTS 316
17.2 AJINOMOTO CO., INC. 317
17.2.1 COMPANY SNAPSHOT 317
17.2.2 REVENUE ANALYSIS 317
17.2.3 COMPANY SHARE ANALYSIS 318
17.2.4 PRODUCT PORTFOLIO 318
17.2.5 RECENT DEVELOPMENTS 319
17.3 NOW FOODS 320
17.3.1 COMPANY SNAPSHOT 320
17.3.2 COMPANY SHARE ANALYSIS 320
17.3.3 PRODUCT PORTFOLIO 321
17.3.4 RECENT DEVELOPMENTS 321
17.4 MUSCLEPHARM 322
17.4.1 COMPANY SNAPSHOT 322
17.4.2 REVENUE ANALYSIS 322
17.4.3 COMPANY SHARE ANALYSIS 323
17.4.4 PRODUCT PORTFOLIO 323
17.4.5 RECENT DEVELOPMENTS 323
17.5 JARROW FORMULAS, INC 324
17.5.1 COMPANY SNAPSHOT 324
17.5.2 COMPANY SHARE ANALYSIS 324
17.5.3 PRODUCT PORTFOLIO 325
17.5.4 RECENT DEVELOPMENTS 325
17.6 ALLMAX 326
17.6.1 COMPANY SNAPSHOT 326
17.6.2 PRODUCT PORTFOLIO 326
17.6.3 RECENT DEVELOPMENTS 326
17.7 BEVERLY INTERNATIONAL 327
17.7.1 COMPANY SNAPSHOT 327
17.7.2 PRODUCT PORTFOLIO 327
17.7.3 RECENT DEVELOPMENT 327
17.8 BIOVEA 328
17.8.1 COMPANY SNAPSHOT 328
17.8.2 PRODUCT PORTFOLIO 328
17.8.3 RECENT DEVELOPMENTS 328
17.9 CELLUCOR 329
17.9.1 COMPANY SNAPSHOT 329
17.9.2 PRODUCT PORTFOLIO 329
17.9.3 RECENT DEVELOPMENTS 329
17.10 EVLUTION NUTRITION 330
17.10.1 COMPANY SNAPSHOT 330
17.10.2 PRODUCT PORTFOLIO 330
17.10.3 RECENT DEVELOPMENTS 330
17.11 FIVE PERCENT NUTRITION, LLC. 331
17.11.1 COMPANY SNAPSHOT 331
17.11.2 PRODUCT PORTFOLIO 331
17.11.3 RECENT DEVELOPMENTS 331
17.12 GAT WHP 332
17.12.1 COMPANY SNAPSHOT 332
17.12.2 PRODUCT PORTFOLIO 332
17.12.3 RECENT DEVELOPMENTS 333
17.13 KAGED 334
17.13.1 COMPANY SNAPSHOT 334
17.13.2 PRODUCT PORTFOLIO 334
17.13.3 RECENT DEVELOPMENT 334
17.14 NUTRABIO LABS, INC. 335
17.14.1 COMPANY SNAPSHOT 335
17.14.2 PRODUCT PORTFOLIO 335
17.14.3 RECENT DEVELOPMENTS 335
17.15 OPTIMUM NUTRITION 336
17.15.1 COMPANY SNAPSHOT 336
17.15.2 PRODUCT PORTFOLIO 336
17.15.3 RECENT DEVELOPMENT 337
17.16 PROSUPPS USA, LLC 338
17.16.1 COMPANY SNAPSHOT 338
17.16.2 PRODUCT PORTFOLIO 338
17.16.3 RECENT DEVELOPMENT 339
17.17 RELIANCE PRIVATE LABEL SUPPLEMENTS 340
17.17.1 COMPANY SNAPSHOT 340
17.17.2 PRODUCT PORTFOLIO 340
17.17.3 RECENT DEVELOPMENTS 340
17.18 SOLGAR INC. 341
17.18.1 COMPANY SNAPSHOT 341
17.18.2 PRODUCT PORTFOLIO 341
17.18.3 RECENT DEVELOPMENT 342
17.19 TRUE NUTRITION 343
17.19.1 COMPANY SNAPSHOT 343
17.19.2 PRODUCT PORTFOLIO 343
17.19.3 RECENT DEVELOPMENTS 343
17.20 UNIVERSAL NUTRITION 344
17.20.1 COMPANY SNAPSHOT 344
17.20.2 PRODUCT PORTFOLIO 344
17.20.3 RECENT DEVELOPMENTS 344
18 QUESTIONNAIRE 345
19 RELATED REPORTS 348

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.